B.Riley analyst Madison El-Saadi initiates coverage on Spruce Biosciences, Inc. (NASDAQ: SPRB) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage